logo-loader
viewKromek Group PLC

Kromek CEO thrilled with maiden underlying profit in latest full year results

Dr Arnab Basu, chief executive of Kromek Group PLC (LON:KMK), discusses with Proactive's Andrew Scott their results for the year to the end of April 2018.

Revenue increased 32% in the period to £11.8mln compared to £9mln the previous year.

Dr Basu says it was a milestone year for the group as revenue growth from a ramp-up in commercial activities saw them post a positive EBITDA for the first time.

Quick facts: Kromek Group PLC

Price: 17.25 GBX

AIM:KMK
Market: AIM
Market Cap: £59.45 m
Follow

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

In exchange for publishing services rendered by the Company on behalf of Kromek Group PLC named herein, including the promotion by the Company of Kromek Group PLC in any Content on the Site, the Company receives from...

FOR OUR FULL DISCLAIMER CLICK HERE

Watch

Investor Update: Lekoil agrees deal to drill up to five new wells in Nigeria

Top stories from the Proactive Investors UK newsroom. Kromek (LON:KMK) has been awarded three contracts worth £1.6mln for its D3S platform for nuclear radiation detection. The largest contract, worth £1.1mln, is with a UK government-related company. Avation (LON:AVAP) has seen another...

on 1/7/19

2 min read